Univest
Univest
  • Markets

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Fall Streak: stock trades lower in second straight session

  • September 2, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
MANIPAL HEALTH ENTERPRI L Share Price Fall Streak
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) share price fell to Rs 664.75 today, down 2.03% from the previous close. Market cap was Rs 92,221.1 crore.

MANIPAL HEALTH ENTERPRI L Share Price Fall Streak is in focus because the stock has moved lower for a second straight session, taking the latest traded price to Rs 664.75 and the cumulative decline to -5.18% from the streak base of Rs 701.1. The event is confirmed by price data alone, and no company-specific trigger is established in the facts. MANIPAL HEALTH ENTERPRI L Share Price Fall Streak therefore reflects a short, two-session breakdown that deserves attention on its own.

MANIPAL HEALTH ENTERPRI L Share Price Fall Streak also matters because the move is not isolated. A second lower session shows that the stock has already repriced across consecutive trading sessions, and the latest quote remains below the earlier starting level of the streak. For readers tracking a large listed healthcare name, that makes the decline more relevant than a one-day dip.

Table of Contents

Toggle
  • MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Fall Streak: Consecutive Decline Analysis
  • What the Consecutive Declines Show
  • MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching MANIPAL HEALTH ENTERPRI L
  • About MANIPAL HEALTH ENTERPRI L
  • Track MANIPAL HEALTH ENTERPRI L Share Price on Univest
  • Frequently Asked Questions
    • What is MANIPAL HEALTH ENTERPRI L Share Price Fall Streak today?
    • How much did MANIPAL HEALTH ENTERPRI L share price fall today?
    • Why is MANIPAL HEALTH ENTERPRI L falling today?
    • What does MANIPAL HEALTH ENTERPRI L share price movement show?
    • What is MANIPAL HEALTH ENTERPRI L market capitalisation?
    • How does MANIPAL HEALTH ENTERPRI L valuation look now?
    • How does MANIPAL HEALTH ENTERPRI L compare with healthcare peers?
    • What are the key profitability metrics for MANIPAL HEALTH ENTERPRI L?
    • Should investors track MANIPAL HEALTH ENTERPRI L Share Price on Univest?

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Fall Streak: Consecutive Decline Analysis

Metric Value
Current Price Rs 664.75
Previous Close Rs 678.55
Today's Move -Rs 13.80 (-2.03%)
Open Rs 684.65
High Rs 684.65
Low Rs 660.85
Market Capitalisation Rs 92,221.1 crore

MANIPAL HEALTH ENTERPRI L Share Price Fall Streak opened at Rs 684.65 and traded between Rs 684.65 and Rs 660.85 during the session before last trading at Rs 664.75. That leaves the stock Rs 13.80 below the previous close of Rs 678.55, which matches a 2.03% decline in the latest update. The day’s range shows that the stock spent the session under pressure after the open, with the latest price sitting closer to the lower end of the band.

The large market capitalisation of Rs 92,221.1 crore places the company in the Large Cap category. In the context of MANIPAL HEALTH ENTERPRI L Share Price Fall Streak, the key point is that the latest session follows another lower session, so the decline is now being viewed across the full two-session run rather than as a single-day move.

What the Consecutive Declines Show

MANIPAL HEALTH ENTERPRI L Share Price Fall Streak is best understood as a cumulative 5.18% decline from Rs 701.1 to Rs 664.75 over two consecutive trading sessions. The latest session is still trading, so the focus remains on the live price rather than a finished close. This is the clearest way to read the move: consecutive lower sessions have already carried the stock noticeably below its starting base.

The streak matters because the second lower session confirms that selling pressure has continued beyond an isolated fall. MANIPAL HEALTH ENTERPRI L Share Price Fall Streak therefore shows a short but meaningful reset in price, with the stock now below both the earlier streak base and the previous close. The data supports the decline, but it does not assign a trigger.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis

Metric Value
Market Capitalisation Rs 92,221.1 crore
P/E Ratio 100.03x
P/B Ratio 5.38x
ROE 12.95%
ROCE 13.93%
EPS Rs 6.78
Book Value Per Share Rs 126.18
Dividend Yield 0%

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) fundamental metrics show P/E 100.03x, P/B 5.38x, ROE 12.95%, ROCE 13.93%. Read together, these ratios describe the company’s position rather than a recommendation.

MANIPAL HEALTH ENTERPRI L has a market capitalisation of Rs 92,221.10 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 100.03x, P/B at 5.38x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.95% and ROCE of 13.93%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.78, book value per share of Rs 126.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 43.52x, median ROE of 12.95%, median ROCE of 15.83%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 100.03x
Benchmark Median P/E 43.52x
Benchmark Average P/E 92.6x
Benchmark P/E Range 6.88x to 1,484.86x
Company P/B Ratio 5.38x
Benchmark Median P/B 3.75x
Benchmark Average P/B 4.06x
Company ROE 12.95%
Benchmark Median ROE 12.95%
Benchmark Average ROE 11.39%
Company ROCE 13.93%
Benchmark Median ROCE 15.83%
Benchmark Average ROCE 2.31%
Company Market Capitalisation Rs 92,221.1 crore
Benchmark Median Market Cap Rs 507.76 crore
Benchmark Average Market Cap Rs 10,399.06 crore

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 100.03x, which is above the benchmark median of 43.52x, a difference of +129.85%. The P/E comparison frames valuation; it is not a signal to buy or sell.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROE of 12.95%, which is equal to the benchmark median of 12.95%, a difference of 0%. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROCE of 13.93%, which is below the benchmark median of 15.83%, a difference of -12%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Apollo Hospitals Enterprise APOLLOHOSP 1,15,315.29 53.71 11.59 23.54 21.73
Max Healthcare Institute MAXHEALTH 86,040.63 58.05 7.74 14.53 14.97
Aster DM Healthcare ASTERDM 61,012.71 186.48 14.05 13.07 16.22
Fortis Healthcare FORTIS 59,271.76 54.57 5.63 11.32 14.07
Global Health MEDANTA 35,327.46 63.25 8.55 15.12 19.38

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 100.03x compared with the displayed peer median of 58.05x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 12.95% compares with a peer median of 14.53% across the companies shown in the table. ROCE stood at 13.93% versus the displayed peer median of 16.22%, providing a capital-efficiency comparison. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a market capitalisation of Rs 92,221.1 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching MANIPAL HEALTH ENTERPRI L

MANIPAL HEALTH ENTERPRI L Share Price Fall Streak remains on watch because it combines a second straight lower session with valuation that still sits above the industry median. The latest traded price of Rs 664.75 is below the previous close of Rs 678.55, and the cumulative decline from Rs 701.1 is already -5.18%. That keeps the stock under close review.

  • MANIPAL HEALTH ENTERPRI L Share Price Fall Streak now shows two consecutive lower sessions.
  • The cumulative move across the streak is -5.18% from Rs 701.1.
  • The latest traded price of Rs 664.75 remains below the previous close of Rs 678.55.
  • P/E of 100.03x and P/B of 5.38x keep valuation in focus.
  • ROE of 12.95% and ROCE of 13.93% provide the current return backdrop.

About MANIPAL HEALTH ENTERPRI L

MANIPAL HEALTH ENTERPRI L Share Price Fall Streak belongs to a Healthcare company in the Hospital & Healthcare Services industry. The business sits in the Large Cap bracket, which makes the current lower run relevant to readers following sector pricing and not just day-to-day trading. The latest data keeps the focus on the stock’s price path, valuation and peer positioning.

For readers of Univest, MANIPAL HEALTH ENTERPRI L Share Price Fall Streak is best viewed as a short sequence of lower prices in a large healthcare name rather than as a broader market thesis. The company’s market capitalisation, valuation and return ratios are all part of that context.

Track MANIPAL HEALTH ENTERPRI L Share Price on Univest

Use MANIPAL HEALTH ENTERPRI L (MANIPALHOS) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Univest lets readers follow MANIPAL HEALTH ENTERPRI L Share Price Fall Streak alongside live price updates, fundamental ratios, market capitalisation and sector comparisons in one place. That makes it easier to keep the decline in view without losing the broader healthcare context.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is MANIPAL HEALTH ENTERPRI L Share Price Fall Streak today?

Ans. MANIPAL HEALTH ENTERPRI L Share Price Fall Streak is showing a second straight session of lower pricing. The latest traded price is Rs 664.75, against a previous close of Rs 678.55, with the cumulative streak move at -5.18% from Rs.

How much did MANIPAL HEALTH ENTERPRI L share price fall today?

Ans. The share price fell Rs 13.80, which equals a 2.03% decline from the previous close of Rs 678.55. The latest traded price stood at Rs 664.75, while the day moved between Rs 684.65 and Rs 660.85.

Why is MANIPAL HEALTH ENTERPRI L falling today?

Ans. Univest data confirms the move itself, though no company-specific trigger has been identified. The streak itself is visible in the price data, showing two consecutive lower sessions and a cumulative move of -5.18% from Rs 701.1.

What does MANIPAL HEALTH ENTERPRI L share price movement show?

Ans. It shows a lower price trend across two consecutive sessions rather than one isolated decline. The latest traded price at Rs 664.75 is below both the previous close and the streak starting base.

What is MANIPAL HEALTH ENTERPRI L market capitalisation?

Ans. The market capitalisation stands at Rs 92,221.1 crore, which places the company in the Large Cap category. That scale matters when reading MANIPAL HEALTH ENTERPRI L Share Price Fall Streak alongside sector and peer context.

How does MANIPAL HEALTH ENTERPRI L valuation look now?

Ans. The company trades at a P/E of 100.03x and a P/B of 5.38x. EPS is Rs 6.78 and book value per share is Rs 126.18, so the current streak leaves the valuation tied to the same earnings and book base.

How does MANIPAL HEALTH ENTERPRI L compare with healthcare peers?

Ans. Its P/E is above Apollo Hospitals, Max Healthcare, Fortis and Global Health in the table shown here. ROE and ROCE sit in the middle of the peer set, while the market capitalisation is below Apollo’s and above several smaller peers.

What are the key profitability metrics for MANIPAL HEALTH ENTERPRI L?

Ans. ROE is 12.95% and ROCE is 13.93%. Those returns sit around the middle of the healthcare comparison set, while valuation remains higher than the industry median. The relevant peer median ROCE is 15.83%.

Should investors track MANIPAL HEALTH ENTERPRI L Share Price on Univest?

Ans. Readers tracking MANIPAL HEALTH ENTERPRI L Share Price Fall Streak can use Univest to follow live price updates, fundamental ratios, market capitalisation and sector comparisons. That keeps the stock view connected to valuation and peer context.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply